Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Lycopene for Oral Lichen Planus
NCT00656214Phase 2Completed
- Sponsor
- College of Dental Sciences
- Start
- Dec 2004
- Primary completion
- May 2006
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in oral lichen planus (OLP) comparing Lycopene with Placebo (2 arms). Primary endpoint: Relief from signs & symptoms of disease at 8 weeks. Started Dec 2004; status: completed.
02
Drugs
lycopene
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT00656214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656214.